| Variables | Population (n = 55) |
| Demographics |
|
| Age (mean ± SD, years) | 30.3 ± 13.1 |
| Gender (women:men) | 53:2 |
| Caucasian vs no causasian | 34.5:65.5 |
| Smokers vs no smokers | 9:46 |
| Disease characteristics |
|
| Disease duration* (mean ± SD, years) | 4.2 ± 9.6 |
| Self-reported symptoms |
|
| Alopecia, n(%) | 41 (74.5) |
| Raynaud phenomenon, n(%) | 11 (20) |
| Skin lesions, n(%) | 34 (61.8) |
| Dyspnea**, n(%) | 25 (45.4) |
| Pleuritic chest pain**, n(%) | 19 (34.5) |
| Dry cough**, n(%) | 16 (29.1) |
| Productive cough**, n(%) | 2 (3.6) |
| Medications at study entry |
|
| Prednisone (yes/no) | 45 |
| Methotrexate (yes/no) | 10 |
| Hydroxychloroquine (yes/no) | 50 |
| Mycophenolate mofetil (yes/no) | 03 |
| Azathioprine (yes/no) | 05 |